TRIZULJAK, Jakub, Martina DOUBKOVÁ, Anna HRAZDIROVÁ, Zuzana VRZALOVÁ, Ivona BLAHÁKOVÁ, Lenka RADOVÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A rare diagnosis: Hermansky-Pudlak syndrome in a patient with pulmonary fibrosis, oculocutaneous albinism and thrombocytopathy. In ESHG 2019, Gothenburg, Sweden. 2019. ISSN 1018-4813.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A rare diagnosis: Hermansky-Pudlak syndrome in a patient with pulmonary fibrosis, oculocutaneous albinism and thrombocytopathy
Authors TRIZULJAK, Jakub (703 Slovakia, belonging to the institution), Martina DOUBKOVÁ (203 Czech Republic, belonging to the institution), Anna HRAZDIROVÁ (203 Czech Republic, belonging to the institution), Zuzana VRZALOVÁ (203 Czech Republic, belonging to the institution), Ivona BLAHÁKOVÁ (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Michael DOUBEK (203 Czech Republic, belonging to the institution).
Edition ESHG 2019, Gothenburg, Sweden, 2019.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10608 Biochemistry and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.657
RIV identification code RIV/00216224:14110/19:00108576
Organization unit Faculty of Medicine
ISSN 1018-4813
UT WoS 000489313901153
Keywords in English Hermansky-Pudlak syndrome
Tags rivok
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 30/3/2020 14:30.
Abstract
Hermansky-Pudlak Syndrome (HPS) is an autosomal recessive disorder associated with oculocutaneous albinism, bleeding diathesis, granulomatous colitis, and highly penetrant pulmonary fibrosis in some subtypes. Homozygous or compound heterozygous mutations in HPS1, HPS3, HPS4 and several other genes lead to clinical manifestation of the disease.
Links
MUNI/A/1105/2018, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VI (Acronym: VýDiTeHeMA VI)
Investor: Masaryk University, Category A
NV16-29447A, research and development projectName: Vyhledávání mutací predisponujících k familiárním hematologickým a onkologickým onemocněním
PrintDisplayed: 17/7/2024 06:56